[go: up one dir, main page]

BR9809111A - Novos intermediários e processo para sua preparação - Google Patents

Novos intermediários e processo para sua preparação

Info

Publication number
BR9809111A
BR9809111A BR9809111-5A BR9809111A BR9809111A BR 9809111 A BR9809111 A BR 9809111A BR 9809111 A BR9809111 A BR 9809111A BR 9809111 A BR9809111 A BR 9809111A
Authority
BR
Brazil
Prior art keywords
preparation
new intermediaries
generic formula
intermediaries
vii
Prior art date
Application number
BR9809111-5A
Other languages
English (en)
Other versions
BR9809111B1 (pt
Inventor
Maria Bakonyi
Marianna Csatarine Nagy
Leventene Molnar
Zoltan Makovi
Piroska Jobb
Tiborne Bai
Original Assignee
Sanofi Synthelabo Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo Inc filed Critical Sanofi Synthelabo Inc
Publication of BR9809111A publication Critical patent/BR9809111A/pt
Publication of BR9809111B1 publication Critical patent/BR9809111B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Press Drives And Press Lines (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

"NOVOS INTERMEDIáRIOS E PROCESSO PARA SUA PREPARAçãO" Trata-se de um processo para preparação de 2 - [ (2-yirnil) -etil-amino] - (2-halogeno-fenil) -acetamidas de fórmula genérica (VII), partindo das nitrila de fórmula genérica (I). Os compostos da fórmula genérica (VII) são intermediários valiosos.
BRPI9809111-5A 1997-05-13 1998-05-11 intermediários de [2-(2-tienil) etilamino]-(2-clorofenil) acetamida e processo para preparação dos mesmos. BR9809111B1 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU9700884A HU225503B1 (en) 1997-05-13 1997-05-13 Novel 2-(2-halophenyl)-2-(2-(2-thienyl)-ethylamino)-acetamides and process for producing them
PCT/HU1998/000047 WO1998051681A1 (en) 1997-05-13 1998-05-11 New intermediates and process for the preparation thereof

Publications (2)

Publication Number Publication Date
BR9809111A true BR9809111A (pt) 2000-08-01
BR9809111B1 BR9809111B1 (pt) 2009-05-05

Family

ID=89995117

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI9809111-5A BR9809111B1 (pt) 1997-05-13 1998-05-11 intermediários de [2-(2-tienil) etilamino]-(2-clorofenil) acetamida e processo para preparação dos mesmos.

Country Status (13)

Country Link
US (1) US6258961B1 (pt)
EP (1) EP0981524B1 (pt)
JP (1) JP4282770B2 (pt)
AT (1) ATE238294T1 (pt)
AU (1) AU7444798A (pt)
BR (1) BR9809111B1 (pt)
CA (1) CA2289545C (pt)
DE (1) DE69813792T2 (pt)
ES (1) ES2195335T3 (pt)
HU (1) HU225503B1 (pt)
NO (1) NO324039B1 (pt)
PT (1) PT981524E (pt)
WO (1) WO1998051681A1 (pt)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU226421B1 (en) 1998-11-09 2008-12-29 Sanofi Aventis Process for racemizing optically active 2-(2-chlorophenyl)-2-(2-(2-thienyl)-ethylamino)-acetamides
US6495691B1 (en) 2001-07-06 2002-12-17 Brantford Chemicals Inc. Process for the preparation of tetrahydrothieno[3,2-c]pyridine derivatives
GB0125708D0 (en) * 2001-10-26 2001-12-19 Generics Uk Ltd Novel compounds and processes
US6767913B2 (en) 2001-12-18 2004-07-27 Teva Pharmaceutical Industries Ltd. Crystal forms iii, iv, v, and novel amorphous form of clopidogrel hydrogensulfate, processes for their preparation, processes for the preparation of form i, compositions containing the new forms and methods of administering the new forms
US7074928B2 (en) 2002-01-11 2006-07-11 Teva Pharmaceutical Industries, Ltd. Polymorphs of clopidogrel hydrogensulfate
IL166593A0 (en) 2002-08-02 2006-01-15 Racemization and enantiomer separation of clopidogrel
US6800759B2 (en) 2002-08-02 2004-10-05 Teva Pharmaceutical Industries Ltd. Racemization and enantiomer separation of clopidogrel
EP1603920A1 (en) 2003-03-12 2005-12-14 Cadila Healthcare Ltd. Polymorph and amorphous form of (s)-(+)-clopidogrel bisulfate
US6858734B2 (en) * 2003-04-23 2005-02-22 Rhodia Pharma Solutions Inc. Preparation of (S)-Clopidogrel and related compounds
WO2004108665A2 (en) * 2003-04-24 2004-12-16 Sun Pharmaceutical Industries Limited A process for preparation of clopidogrel
GB0321256D0 (en) 2003-09-11 2003-10-08 Generics Uk Ltd Novel crystalline compounds
DK1680430T3 (da) 2003-11-03 2010-05-25 Cadila Healthcare Ltd Fremgangsmåder til fremstilling af form I af (S)-(+)-Clopidogrel-bisulfat
PT1589019E (pt) * 2004-04-20 2008-10-08 Ratiopharm Gmbh Processo estereosselectivo para a preparação de clopidogrel
JP2007513889A (ja) * 2004-09-21 2007-05-31 テバ ファーマシューティカル インダストリーズ リミティド 結晶性クロピドグレル臭酸塩及びその調製方法
US20060223845A1 (en) * 2005-02-24 2006-10-05 Eran Turgeman Clopidogrel base suitable for pharmaceutical formulation and preparation thereof
MX2008013724A (es) * 2006-04-27 2009-06-19 Ind Swift Lab Ltd Proceso para la preparacion de formas polimorficas de hidrogeno sulfato clopidrogel.
TW200825093A (en) * 2006-08-03 2008-06-16 Teva Pharma Process for preparing clopidogrel bisulphate
PL382055A1 (pl) * 2007-03-23 2008-09-29 Koźluk Tomasz Nobilus Ent Sposób wytwarzania formy krystalicznej 1 wodorosiarczanu klopidogrelu
EP1980563A1 (en) 2007-04-09 2008-10-15 BATTULA, Srinivasa Reddy Procedure for the preparation of methyl (+)-(S)-Alpha-(O-chlorophenyl)-6,7-dihydrothieno-[3,2-C]pyridine-5(4H) acetate
EP2107061A1 (en) 2008-04-02 2009-10-07 Krka Tovarna Zdravil, D.D., Novo Mesto Process for the preparation of optically enriched clopidogrel
US20090264460A1 (en) * 2008-04-21 2009-10-22 Mamta Mishra Clopidogrel pharmaceutical formulations
US20110190502A1 (en) * 2008-10-24 2011-08-04 Sandoz Ag Process for the preparation of s-clopidogrel
US8563690B2 (en) * 2008-11-03 2013-10-22 The Board Of Trustees Of The University Of Illinois Modulation of platelet aggregation
CN103483356B (zh) * 2013-09-30 2016-01-13 浙江美诺华药物化学有限公司 一种（s）-氯吡格雷的硫酸盐或盐酸盐的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2530247B1 (fr) 1982-07-13 1986-05-16 Sanofi Sa Nouveaux derives de la thieno (3, 2-c) pyridine, leur procede de preparation et leur application therapeutique
FR2608607B1 (fr) 1986-12-23 1989-04-28 Sanofi Sa Procede de preparation de thienylethylamines et dithienylethylamines ainsi obtenues
FR2623810B2 (fr) * 1987-02-17 1992-01-24 Sanofi Sa Sels de l'alpha-(tetrahydro-4,5,6,7 thieno(3,2-c) pyridyl-5) (chloro-2 phenyl) -acetate de methyle dextrogyre et compositions pharmaceutiques en contenant
FR2652575B1 (fr) 1989-09-29 1992-01-24 Sanofi Sa Procede de preparation d'acides alpha-bromo phenylacetiques.
FR2664596B1 (fr) * 1990-07-10 1994-06-10 Sanofi Sa Procede de preparation d'un derive n-phenylacetique de tetrahydrothieno [3,2-c] pyridine et son intermediaire de synthese.

Also Published As

Publication number Publication date
DE69813792T2 (de) 2004-01-29
ES2195335T3 (es) 2003-12-01
HUP9700884A2 (hu) 1999-09-28
CA2289545A1 (en) 1998-11-19
NO995532D0 (no) 1999-11-12
EP0981524B1 (en) 2003-04-23
JP4282770B2 (ja) 2009-06-24
HUP9700884A3 (en) 2000-06-28
NO995532L (no) 1999-12-13
DE69813792D1 (de) 2003-05-28
PT981524E (pt) 2003-08-29
ATE238294T1 (de) 2003-05-15
CA2289545C (en) 2006-12-12
NO324039B1 (no) 2007-07-30
HU9700884D0 (en) 1997-07-28
JP2001525818A (ja) 2001-12-11
HU225503B1 (en) 2007-01-29
US6258961B1 (en) 2001-07-10
AU7444798A (en) 1998-12-08
BR9809111B1 (pt) 2009-05-05
WO1998051681A1 (en) 1998-11-19
EP0981524A1 (en) 2000-03-01

Similar Documents

Publication Publication Date Title
BR9809111A (pt) Novos intermediários e processo para sua preparação
BR9809113A (pt) Novos intermediários e processo para sua preparação
NO984344L (no) Ny asymmetriske syntese av R-<alfa>-propylpiperonyalamin og dets analoger
BR9809687A (pt) Processo novo
ES2109103T3 (es) Procedimiento para la preparacion de trialquilsilil-7 bacatina iii.
SE8601646D0 (sv) Intermediates for the production of epipodophyllotoxin and related compounds and processes for the preparation and use thereof
PT1000067E (pt) Tiazolobenzo-heterociclos sua preparacao e medicamentos que os contem
BR9807785A (pt) Processo para a preparação do composto, e, composto
NO940113L (no) Syntese av 2-fenyl-substituerte 1,3-propandioler
DK0975601T3 (da) Fremgangsmåde til fremstilling af butylthio-isoquinolin og mellemprodukter derfor
BR0012481A (pt) Processo para desacilação de lipodepsipeptìdeos
ES2001809A6 (es) Un procedimiento para la preparacion de nuevas 3-(4,-fenil-piperazinil)alquil-quinazolin-2,4-(1h,3h)-dionas sustituidas
BR0016781A (pt) Bases de 1-naftol e 2-naftol - mannich substituìdas
BR9803388A (pt) Processo para a preparação de um composto de 4,6-bi (arilóxi)-pirimidina assimétrico.
BR9909756A (pt) Processo para a preparação de um composto
BR9907340A (pt) Ciclo-heptenos substituìdos, e processo para a produção de um composto
ES2152490T3 (es) Transformacion de 8-cloroquinoleinas sustituidas en 8-hidroxiquinoleinas sustituidas.
ES2192324T3 (es) Procedimiento para preparar una feniltiobutil-isoquinolina y sus intermedios.
ES2188222T3 (es) Sintesis enantioselectiva.
DK0675880T3 (da) Quinolondisulfider som mellemprodukter
FI870058A0 (fi) Foerfarande foer framstaellning av baernstenssyramon/(2-dimetylamino)etylester/succinat.
DE59002172D1 (de) Neue 1,3-oxazine.
ES2172699T3 (es) Procedimiento para la preparacion de prostaglandina e1.
PT83055B (pt) Processo de sintese, para a preparacao de um novo benzodioxepano
CO5031300A1 (es) PROCESO PARA LA PRODUCCION DE N-[(1- BUTIL-4-PIPERIDINIL)] 3,4-DIHIDRO-2H-[1,3]OXAZINO[3,2-a]INDOL-10-CARBOXAMIDA O UNA SAL FARMACEUTICAMENTE ACEPTABLE

Legal Events

Date Code Title Description
B25G Requested change of headquarter approved
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B25D Requested change of name of applicant approved

Owner name: SANOFI-AVENTIS (FR)

Free format text: ALTERADO DE: SANOFI-SYNTHELABO

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 28/07/2009, OBSERVADAS AS CONDICOES LEGAIS.

B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]

Free format text: PATENTE EXTINTA EM 28.07.2019